Clinical Trials | December 28, 2023
Innovent Biologics, Xuanzhu collaborate on clinical trial for advanced solid tumors in China
Innovent will supply sintilimab for the collaborated clinical trial
Innovent will supply sintilimab for the collaborated clinical trial
Astellas has acquired abiraterone decanoate being developed by Propella to treat prostate cancer
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
Cresemba is the only azole antifungal therapy approved for pediatric patients as young as one affected by these serious, potentially life-threatening infections
Express Scripts to add Zepbound to National Preferred Formulary
This approval showcases Teva’s proven strengths in complex generic formulations development and device engineering
Phase 3 data expected in the second half of 2024
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
The companies plan to start a pivotal Phase 3 trial in the coming months
The sBLA is supported by a usability study which confirmed that individuals over 18 years of age could self-administer
Subscribe To Our Newsletter & Stay Updated
